Beyond HAART: Innovative Therapies to Control HIV-1 (P01)

Post Date

April 20th 2011

Application Due Date

July 19th 2011

Funding Opportunity Number

RFA-AI-11-012

CFDA Number(s)

93.242
93.855
93.856

Funding Instrument Type(s)

Grant

Funding Activity Categories

Health

Eligibility Categories

State Governments
County Governments
City or Township Governments
Special District Governments
Independent School Districts
Public and State Controlled Institutions of Higher Education
Federally Recognized Native American Tribal Governments
Public Housing Authorities or Indian Housing Authorities
Non-Federally Recognized Native American Tribal Organizations
Non-Profits With 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Non-Profits Without 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Private Institutions of Higher Education
For-Profit Organizations (Except Small Businesses)
Small Businesses
Other

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Foreign (non-U.S.) components of U.S. Organizations are notallowed. Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to serve as primary applicants for this FOA. However, a research project(s) or scientific core(s), originating at a foreign organization, may be submitted as part of a program project application submitted by a domestic institution or organization.

Funding

• Award Range:

  $None - $None

Grant Description

The National Institute of Allergy and Infectious Diseases (NIAID) and the National Institute of Mental Health (NIMH), NIH encourage applications from institutions/organizations to participate in this Funding Opportunity Announcement (FOA), Beyond HAART: Innovative Therapies to Control HIV-1. This initiative will support program project applications to develop therapeutic approaches that could allow HIV-1 infected persons to discontinue current HIV-1 treatments for a sustained period without viral rebound. Approaches of interest include therapeutic vaccines, gene therapies, cell therapies, antibodies, and other targeted interventions. Awardees will perform basic research on the chosen approach, as well as engage in translational activities such as test-of-concept studies in animal models or humans. Research program project applications must be designed as collaborative efforts between academia and the private sector.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  National Institutes of Health

• Agency Contact:

  NIH OER Webmaster
  FBOWebmaster@OD.NIH.GOV
  

• Agency Mailing Address:

  If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

• Agency Email Address:

  FBOWebmaster@OD.NIH.GOV

• More Information:

  http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-11-012.html